Analysts expect that Lannett Company, Inc. (NYSE:LCI) will announce earnings of $0.27 per share for the current fiscal quarter, Zacks Investment Research reports. Three analysts have provided estimates for Lannett’s earnings. The lowest EPS estimate is $0.23 and the highest is $0.29. Lannett reported earnings per share of $0.86 during the same quarter last year, which indicates a negative year over year growth rate of 68.6%. The company is expected to report its next quarterly earnings results on Wednesday, February 5th.
According to Zacks, analysts expect that Lannett will report full-year earnings of $1.19 per share for the current year, with EPS estimates ranging from $1.10 to $1.23. For the next fiscal year, analysts anticipate that the company will post earnings of $1.52 per share, with EPS estimates ranging from $1.41 to $1.66. Zacks’ EPS calculations are a mean average based on a survey of sell-side research firms that that provide coverage for Lannett.
Lannett (NYSE:LCI) last announced its quarterly earnings data on Wednesday, November 6th. The company reported $0.22 EPS for the quarter, topping analysts’ consensus estimates of $0.19 by $0.03. Lannett had a return on equity of 25.40% and a net margin of 0.52%. The business had revenue of $127.30 million during the quarter, compared to analysts’ expectations of $120.78 million. During the same period in the previous year, the firm earned $0.44 earnings per share. The firm’s quarterly revenue was down 17.9% compared to the same quarter last year.
A number of brokerages recently commented on LCI. ValuEngine raised Lannett from a “strong sell” rating to a “sell” rating in a research note on Friday, January 3rd. Zacks Investment Research raised Lannett from a “strong sell” rating to a “hold” rating in a research note on Tuesday, January 14th.
Institutional investors have recently made changes to their positions in the stock. Tower Research Capital LLC TRC grew its stake in Lannett by 312.5% in the third quarter. Tower Research Capital LLC TRC now owns 3,960 shares of the company’s stock valued at $45,000 after acquiring an additional 3,000 shares during the period. Glen Harbor Capital Management LLC acquired a new position in Lannett in the second quarter valued at about $42,000. Metropolitan Life Insurance Co NY acquired a new position in Lannett in the first quarter valued at about $77,000. Zacks Investment Management acquired a new position in Lannett in the second quarter valued at about $65,000. Finally, Mackay Shields LLC acquired a new position in Lannett in the third quarter valued at about $183,000.
Shares of Lannett stock traded down $0.30 during trading on Tuesday, reaching $9.75. 1,294,411 shares of the company were exchanged, compared to its average volume of 792,483. The company has a quick ratio of 1.60, a current ratio of 2.43 and a debt-to-equity ratio of 2.07. Lannett has a twelve month low of $5.16 and a twelve month high of $15.52. The business has a 50-day moving average price of $8.82 and a 200-day moving average price of $9.22. The firm has a market capitalization of $405.29 million, a price-to-earnings ratio of 139.29 and a beta of 2.12.
Lannett Company, Inc develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, patch, foam, buccal, sublingual, suspension, soft gel, and injectable dosages.
Read More: Correction
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Lannett Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lannett and related companies with MarketBeat.com's FREE daily email newsletter.